Nikkiso Co

Nikkiso Co P/FCF

The P/FCF (Price-to-Free-Cash-Flow Ratio) of Nikkiso Co (6376.T) as of Oct 22, 2026 is 11.36. In the previous year, P/FCF (Price-to-Free-Cash-Flow Ratio) was -11.26 — a change of -200.94% (higher).

P/FCF

11.36

YoY

-200.94%

Last updated:

P/FCF (Price-to-Free-Cash-Flow Ratio) of Nikkiso Co is 2025 11.36 . P/FCF (Price-to-Free-Cash-Flow Ratio) of Nikkiso Co was 2024 -11.26 . It decreases by -200.94% higher compared to the previous year.

The Nikkiso Co P/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/FCF
Date
P/FCF
Jan 1, 2018
66.96 JPY
Jan 1, 2019
29.68 JPY
Jan 1, 2020
-220.12 JPY
Jan 1, 2021
-16.43 JPY
Jan 1, 2022
215.44 JPY
Jan 1, 2023
22.98 JPY
Jan 1, 2024
-11.26 JPY
Jan 1, 2025
11.36 JPY
The Nikkiso Co P/FCF history
YEARP/FCFYoY
11.36-200.94%
-11.26-148.99%
22.98-89.34%
215.44-1,411.40%
-16.43-92.54%
-220.12-841.77%
29.68-55.68%
66.96-132.55%
-205.75-1,069.67%
21.22-113.76%
-154.25-329.60%
67.18—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Nikkiso Co Stock analysis

What does Nikkiso Co do? Nikkiso Co., Ltd. generates revenue through the manufacture, sale, and maintenance of industrial and medical equipment across two distinct business segments. The Industrial Business segment focuses on industrial special pumps, liquefied gas and industrial gas related equipment, as well as precision equipment, aerospace, and deep ultraviolet light emitting diode (LED) products. This segment serves customers requiring specialized industrial machinery and advanced technological components. The Medical Business segment drives income by producing and maintaining dialysis-related products such as artificial dialysis machines, dialyzers, blood circuits, and powder-type dialysis agents. Additionally, the company offers products and medicines for CRRT, artificial pancreas devices for blood glucose management, and energy devices for microwave surgery. These offerings cater to healthcare providers and patients requiring acute blood purification and chronic disease management solutions. Nikkiso Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Nikkiso Co stock

P/FCF (Price-to-Free-Cash-Flow Ratio) of Nikkiso Co is 11.36 in 2025.

P/FCF (Price-to-Free-Cash-Flow Ratio) of Nikkiso Co changed from -11.26 to 11.36, representing a -200.94% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/FCF (Price-to-Free-Cash-Flow Ratio) Nikkiso Co since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Free-Cash-Flow ratio measures how much investors pay for each unit of free cash flow. A lower ratio may indicate better value.

P/FCF = Market Capitalization / Free Cash Flow

To evaluate P/FCF (Price-to-Free-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/FCF (Price-to-Free-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/FCF (Price-to-Free-Cash-Flow Ratio)'s Nikkiso Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Nikkiso Co

All Key Metrics — Nikkiso Co